<DOC>
	<DOC>NCT01324518</DOC>
	<brief_summary>The purpose of this study is to determine whether ORM-12741 is safe and effective in the treatment of Alzheimer's disease.</brief_summary>
	<brief_title>Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease</brief_title>
	<detailed_description>The purpose of this study is to determine whether ORM-12741 is safe and effective in the treatment of cognitive and behavioral symptoms in patients with Alzheimer's disease.</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Informed consent obtained from the patient and legally acceptable representative, if required Informed consent obtained from the caregiver Males and and females between 5590 years Diagnosis of probable Alzheimer's disease, history of progressive cognitive deterioration Brain imaging consistent with Alzheimer's disease Minimental state examination score 1221 Treated with donepezil, rivastigmine or galantamine At least mild level of behavioral symptoms Other types of dementias Modified Hachinski Ischemia Score &gt; 4 Use of memantine, antipsychotics, anticholinergic medication and benzodiazepines (at a max of 3 nights/week) within 2 months Changes in antidepressant dosing within 2 months Use of other psychotropic agents Myocardial infarction within the past 2 years Malignancy within the past 5 years Suicidal ideation, risk of suicide History of alcoholism or drug abuse within 5 years Clinically significant cardiovascular, pulmonary, gastrointestinal, hepatic, renal, neurological or psychiatric disorder or any other major concurrent illness Specific findings in brain imaging Abnormal findings in heart rate, blood pressure, ECG, laboratory tests, physical examination; orthostatic hypotension Blood donation or participation in a drug study within 60 days Previous AD immunotherapy treatment Patient cannot complete the computerised cognitive training Patients who reside in a skilled nursing facility Patients who are not able to swallow capsules</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>